Total-body echo-planar MR imaging in the staging of breast cancer: Comparison with conventional methods - Early experience

Radiology

Volumn 211, Issue 1, 1999, Pages 119-128

  Horvath, Laura J ^a   Burtness, Barbara A ^a   McCarthy, Shirley ^a   Johnson, Kevin M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone neoplasms, radionuclide studies; Breast neoplasms; Neoplasms, CT; Neoplasms, MR; Neoplasms, radionuclide studies; Neoplasms, staging

Indexed keywords

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0032951860     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.211.1.r99ap33119     Document Type: Article

References (28)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancel Statistics, 1997. CA Cancer J Clin 1997; 47:5-27.
2. Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Cancer 1978; 41: 1170-1178.
3. Brown B, Laorr A, Greenspan A, Stadalnik R. Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases. Clin Nucl Med 1994; 19:194-196.
4. Pisentma DA, McDougall R, Kriss JP. Screening for bone metastases, are only scans necessary? JAMA 1975; 231:46-50.
5. Love S, Parker B, Ames M, Taylor C, Gilden R, Figlin RA. Practice guidelines for breast cancer. Cancer J Sci Am 1996; 2 (suppl):7-21.
6. Donegan WL. Staging and primary treatment. In: Donegan WL, Spratt JS, eds. Cancer of the breast. 4th ed. Philadelphia, Pa: Saunders, 1995; 382.
7. Gosfield E, Alavi A, Kneeland B. Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases. J Nucl Med 1993; 34:2191-2198.
8. Algra PR, Bloem JL, Tissing H, Falke THM, Arndt JW, Verboom LJ. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radio-Graphics 1991; 11:219-232.
9. Frank JA, Ling A, Patronas NJ, et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. AJR 1990; 155:1043-1048.
10. Mehta RC, Wilson MA, Perlman SB. False-negative bone scan in extensive metastatic disease: CT and MR findings. J Comput Assist Tomogr 1989; 13:717-719.
11. Avrahami E, Tadmor R, Dally O, Hadar H. Early MR demonstration of spinal metastases in patients with normal radiographs and CT and radionuclide bone scans. J Comput Assist Tomogr 1989; 13:598-602.
12. Sanal SM, Flickinger FW, Caudell MJ, Sherry RM. Detection of bone marrow involvement in breast cancer with magnetic resonance imaging. J Clin Oncol 1994; 12:1415-1421.
13. Rummeny EJ, Wernecke K, Saini S, et al. Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: a receiver operating characteristic analysis. Radiology 1992; 182:879-886.
14. Semelka RC, Shoenut JP, Ascher SM, et al. Solitary hepatic metastasis: comparison of dynamic contrast enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH and dynamic gadolinium-enhanced FLASH sequences. JMRI 1994; 4:319-323.
15. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the radiologic diagnostic oncology group. Radiology 1991; 178:705-713.
16. Webb WR, Gamsu G, Stark DD, Moore EH. Magnetic resonance imaging of the normal and abnormal pulmonary hila. Radiology 1984; 152:89-94.
17. Feuerstein IM, Jicha DL, Pass HI, et al. Pulmonary metastases: MR imaging with surgical correlation - a prospective study. Radiology 1992; 182:123-129.
18. Johnson KM, Leavitt GD, Kayser HWM. Total-body MR imaging in as little as 18 seconds. Radiology 1997; 202:262-267.
19. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer 1987; 55:61-66.
20. Glynne-Jones R, Young T, Ahmed A, Ell PJ, Berry RJ. How far investigations for occult metastases in breast cancer aid the clinician. Clin Oncol 1991; 3:65-72.
21. Kattapuram SV, Khurana JS, Scott JA, El-Khoury GY. Negative scintigraphy with positive magnetic resonance imaging in bone metastases. Skeletal Radiol 1990; 19:113-116.
22. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992; 10:1534-1539.
23. Mansi JL, Easton D, Berger U, et al. Bone marrow micrometastases in primary breast cancer; prognostic significance after 6 years' follow-up. Eur J Cancer 1991; 27: 1552-1555.
24. Cutler SJ. Classification of extent of disease in breast cancer. Semin Oncol 1974; 1:91-96.
25. Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD. Assessment of response to therapy in advanced breast cancer. Cancer 1977; 39:1289-1294.
26. Edelman RR, Wielopolski P, Schmitt F. Echo-planar MR imaging. Radiology 1994; 192:600-612.
27. 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR 1997; 169:1655-1661.
28. Wood JC, Johnson KM. Wavelet packet denoising of magnetic resonance images: importance of Rician noise at low SNR. Magn Reson Med (in press).